The results showed that the levels of plasmatic exosomes expressing PSA were significantly increased in patients with prostate cancer, with significantly higher sensitivity and specificity as compared to the standard serum PSA in the same patients [36]. The gene discussed is KLK3; the disease is prostate cancer.